- Big Pharma is hurting drug innovation. “Pfizer spent $139 billion on share buybacks and dividends in the past decade — and just $82 billion on research and development”. https://www.washingtonpost.com/news/theworldpost/wp/2018/10/17/pharmaceutical/ 50 comments economy
Linking pages
Linked pages
- Goldman asks: 'Is curing patients a sustainable business model?' https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html 6307 comments
- Corporate America's buyback binge feeds investors, starves innovation http://www.reuters.com/investigates/special-report/usa-buybacks-cannibalized/ 21 comments
Related searches:
Search whole site: site:www.washingtonpost.com
Search title: Opinion | The pharmaceutical industry is failing us - The Washington Post
See how to search.